Position in DGX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,053,603
-$49,145 QoQ
Shares Held
4,971
-19.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#479
of 1,088 holders
Holding Since
Mar 2020
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DGX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026GSA CAPITAL PARTNERS LLP holds $16,598,580 across 18 Diagnostics & Research names. DGX ranks #5 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
11,336 | $3,077,157 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
4,702 | $2,357,394 | |
| 3 | GH |
Guardant Health, Inc.
|
11,811 | $1,772,004 | |
| 4 | BDSX |
Biodesix Inc
|
46,989 | $1,059,601 | |
| 5 | DGX |
Quest Diagnostics Inc
This page
|
4,971 | $1,053,603 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
1,981 | $1,042,877 | |
| 7 | XGN |
Exagen Inc.
|
214,721 | $998,452 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
619 | $790,778 |
All Filings in DGX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,053,603 | 4,971 | Shares | Sole | 2026-08-06 | |
| 2025-06-30 | $1,102,748 | 6,139 | Shares | Sole | 2025-07-22 | |
| 2022-09-30 | $232,006 | 1,891 | Shares | Sole | 2022-11-14 | |
| 2021-09-30 | $1,453,390 | 10,002 | Shares | Sole | 2021-11-12 | |
| 2020-12-31 | $565,104 | 4,742 | Shares | Sole | 2021-02-03 | |
| 2020-03-31 | $358,539 | 4,465 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||